poor decision by management to withhold a dividend of any sort.
something stinks when a defensive stock like API , where demand for pharmaceuticals products is huge and interest rates at a low and individual earnings are being hit , API decides to withhold any form of dividend to assist its shareholders , some of whom are cash strapped.
The results , whilst not as good as I expected , still supported at least a 2 cents dividend. given demand for it Pharma products would continue to be strong through autumn and winter , with or without Con19, and especially with Con19 .........see the decision of no dividend as despicable.
API Price at posting:
$1.04 Sentiment: Buy Disclosure: Held